CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Garmindevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05077722
NCT05077722N/ACompleted
CompareCT.gov

PISTACHIO (Preemption Of Disruptive Behavior In Children) Real-Time Monitoring Of Sleep And Behavior Of Children 3-7-Year-Old Receiving Parent Child Interaction Therapy Augmented With Artificial Intelligence Randomized Controlled Trial

Mayo Clinic·interventional·Posted Oct 14, 2021·Updated Mar 22, 2024

In Brief

A clinical study evaluating Garmin for Disruptive Behavior and 2 related conditions. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The purpose of this study is to develop an innovative wearable tracking protocol that will use Artificial Intelligence (AI) technology to monitor sleep and behavior of 3-7 year old children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDisruptive Behavior, Attention-deficit Hyperactivity, Oppositional Defiant Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 14, 2021
Enrollment StartMar 24, 2022
Primary CompletionDec 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.7 years ago

Interventions

Garmindevice

A smartwatch device that measures subjects level of activity, heartrate, respirations and quality of your sleep at night. Artificial intelligence will be applied to analyze all the data over the course of 12 weeks to monitor and attempt to predict the onset of tantrums or disruptive behavior. Subjects are required to wear the watch at least 70% of the day and night each day for 70% of days during 12 weeks of treatment.